𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quantifying subjective assessment of sleep and life-quality in antidepressant-treated depressed patients

✍ Scribed by Andrew G. Mayers; Johanna C. van Hooff; David S. Baldwin

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
69 KB
Volume
18
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

This study sought to establish a method of quantifying subjective perceptions of sleep against perceptions of life‐quality and mood, using amended versions of the Pittsburgh sleep diary (PghSD) and quality of life of insomniacs (QOLI) questionnaire. Diaries and questionnaires were self‐completed in participants' homes. Outpatients with a DSM‐IV diagnosis of major depressive disorder were compared with a healthy control group (with no history, or family history, of depression). Poorer sleepers, as determined by the sleep diary, were significantly more likely to report poorer life‐quality and mood perceptions on the subsequent questionnaire. Furthermore, the depressed group reported significantly poorer perceptions of sleep quality and poorer perceptions of life‐quality and mood than the control group, even though estimates of sleep disturbance were similar. This may indicate that depressed individuals experience more ‘sleep distress’ than healthy individuals. These results confirm the extent of subjectively reported sleep disruption in depression and demonstrate the merit of combining the amended PghSD and QOLI to quantify sleep perceptions. Copyright © 2002 John Wiley & Sons, Ltd. Copyright © 2002 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

Assessing subjective sleep reports in th
Assessing subjective sleep reports in the first-degree relatives of antidepressant-treated depressed outpatients
✍ Andrew G. Mayers; Johanna C. van Hooff; David S. Baldwin 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

## Abstract This study sought to investigate whether first‐degree relatives of depressed patients report, and react to, sleep perceptions in the same way as the depressed group. Our previous research suggested that depressed individuals may experience greater sleep ‘distress’ than healthy individua

Subjective and polysomnographic effects
Subjective and polysomnographic effects of milnacipran on sleep in depressed patients
✍ Patrick Lemoine; Thierry Faivre 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

## Abstract The effects of milnacipran (50 mg bid) on sleep patterns of eight depressed inpatients, treated for 4 weeks, were studied during the initial (days 1–3) and terminal (days 26–28) treatment periods and compared with those obtained from three sleep recordings performed just prior to the in

The Effect of Paroxetine and Dothiepin o
The Effect of Paroxetine and Dothiepin on Subjective Sleep in Depressed Patients
✍ JOHN S. KERR; DIANE B. FAIRWEATHER; IAN HINDMARCH 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

Paroxetine improve the quality of sleep and the ease of waking up on subjective measures of sleep (the LSEQ). Dothiepin in contrast improved the ease of getting to sleep, but caused a reduced quality of sleep and a `hangover' eect the next morning.

Are importance ratings useful in the ass
Are importance ratings useful in the assessment of subjective quality of life in schizophrenic patients?
✍ Dr Michael Franz; Thorsten Meyer; Bernd Gallhofer 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB

## Abstract Subjective quality of life (QOL) is predominantly measured as satisfaction in various life domains. However, this approach has often been criticized for not taking individual preferences into account. A combination of importance and satisfaction ratings allows for the different weights

Impact of the novel antidepressant agome
Impact of the novel antidepressant agomelatine on disturbed sleep–wake cycles in depressed patients
✍ Maria-Antonia Quera-Salva; Patrick Lemoine; Christian Guilleminault 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 1 views

## Abstract ## Background Disturbance of sleep–wake cycles is common in major depressive disorder (MDD), usually as insomnia, but also as hypersomnia or reduced daytime alertness. Agomelatine, an MT~1~ and MT~2~ receptor agonist and 5‐HT~2C~ receptor antagonist, represents a novel approach in MDD,